TMCI
What one share of Treace Medical Concepts holds
Surgical and Medical Instruments and Apparatus
We are a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which we estimate 1.1 million are annual surgical candidates.
Treace Medical Concepts’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.19 |
|---|---|
| Profit | −$0.93 |
| Capex (buildings and equipment) | $0.16 |
| Free cash flow | −$0.39 |
| Cash and investments | $0.70 |
| Debt | $0.91 |
| Book value | $1.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $1.07 | −$0.13 | $0.03 | −$0.24 | — | $0.09 |
| 2020 | $1.55 | −$0.12 | $0.03 | −$0.15 | — | $0.02 |
| 2021 | $1.95 | −$0.43 | $0.06 | −$0.41 | — | $1.72 |
| 2022 | $2.57 | −$0.77 | $0.27 | −$0.82 | — | $1.09 |
| 2023 | $3.08 | −$0.81 | $0.19 | −$0.76 | — | $2.23 |
| 2024 | $3.37 | −$0.90 | $0.19 | −$0.79 | — | $1.80 |
| 2025 | $3.36 | −$0.93 | $0.21 | −$0.47 | — | $1.35 |